HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tami J Pilot-Matias Selected Research

P-300

4/2018Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.
4/2018Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.
1/2018Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tami J Pilot-Matias Research Topics

Disease

5Infections
04/2018 - 06/2004
2Fibrosis (Cirrhosis)
04/2018 - 01/2018

Drug/Important Bio-Agent (IBA)

4glecaprevir and pibrentasvirIBA
04/2018 - 01/2018
3P-300IBA
04/2018 - 01/2018
1Ritonavir (Norvir)FDA Link
04/2018
1paritaprevirIBA
04/2018
1ombitasvirIBA
04/2018
1glecaprevirIBA
01/2018
1Ribavirin (Virazole)FDA LinkGeneric
01/2018
1Antiviral Agents (Antivirals)IBA
01/2018
1pibrentasvirIBA
01/2018
1InterferonsIBA
01/2018
1Protease Inhibitors (Protease Inhibitor)IBA
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1BILN 2061IBA
06/2004
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
06/2004